Tbc1d10c is a selective, constitutive suppressor of the CD8 T-cell anti-tumor response

Cohen, A. O., Woo, S.-H., Zhang, J., Cho, J., Ruiz, M. E., Gong, J., Du, R., Yarygina, O., Jafri, D. Z., Bachelor, M. A., Finlayson, M. O., Soni, R. K., Hayden, M. S., & Owens, D. M. (2022). Tbc1d10c is a selective, constitutive suppressor of the CD8 T-cell anti-tumor response. OncoImmunology, 11(1). https://doi.org/10.1080/2162402x.2022.2141011
Authors:
Adrienne O. Cohen
Seung‐Hyun Woo
Qian Zhang
Jiyoon Cho
Marlon E. Ruiz
Jianli Gong
Rong Du
Olga Yarygina
Danya Z. Jafri
Michael Bachelor
Michael O. Finlayson
Rajesh K. Soni
Matthew S. Hayden
David M. Owens
Affiliated Authors:
Adrienne O. Cohen
Seung‐Hyun Woo
Qian Zhang
Jiyoon Cho
Marlon E. Ruiz
Jianli Gong
Rong Du
Olga Yarygina
Danya Z. Jafri
Michael Bachelor
Michael O. Finlayson
Rajesh K. Soni
David M. Owens
Subjects:
NF-kappa B (MeSH)
Neoplasms (MeSH)
Cancer Immunotherapy (OpenAlex Topic)
Author Keywords:
immuno-oncology
squamous cell carcinoma
melanoma
carabin
nf-kappa b
map3k3
nf-κb
Publication Type:
Article
Unique ID:
10.1080/2162402x.2022.2141011
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: